AU2001273150A1 - Secreted and transmembrane polypeptides and nucleic acids encoding the same - Google Patents

Secreted and transmembrane polypeptides and nucleic acids encoding the same

Info

Publication number
AU2001273150A1
AU2001273150A1 AU2001273150A AU2001273150A AU2001273150A1 AU 2001273150 A1 AU2001273150 A1 AU 2001273150A1 AU 2001273150 A AU2001273150 A AU 2001273150A AU 2001273150 A AU2001273150 A AU 2001273150A AU 2001273150 A1 AU2001273150 A1 AU 2001273150A1
Authority
AU
Australia
Prior art keywords
secreted
same
nucleic acids
acids encoding
transmembrane polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001273150A
Inventor
Kevin P. Baker
Luc Desnoyers
Mary E. Gerritsen
Audrey Goddard
Paul J Godowski
J. Christopher Grimaldi
Austin L. Gurney
Victoria Smith
Jean-Philippe F. Stephan
Colin K. Watanabe
William I. Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2000/020710 external-priority patent/WO2001009327A2/en
Priority claimed from PCT/US2000/023522 external-priority patent/WO2001016319A2/en
Priority claimed from PCT/US2000/023328 external-priority patent/WO2001016318A2/en
Priority claimed from PCT/US2000/030873 external-priority patent/WO2001040465A2/en
Priority claimed from PCT/US2000/032678 external-priority patent/WO2001040466A2/en
Priority claimed from PCT/US2000/034956 external-priority patent/WO2001046420A2/en
Priority claimed from US09/747,259 external-priority patent/US6569645B2/en
Priority claimed from PCT/US2001/006520 external-priority patent/WO2001068848A2/en
Priority claimed from PCT/US2001/006666 external-priority patent/WO2001066740A2/en
Priority claimed from US09/816,744 external-priority patent/US6579520B2/en
Priority claimed from US09/854,280 external-priority patent/US7115398B2/en
Priority claimed from PCT/US2001/017092 external-priority patent/WO2001092331A2/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AU2001273150A1 publication Critical patent/AU2001273150A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2001273150A 2000-07-20 2001-06-29 Secreted and transmembrane polypeptides and nucleic acids encoding the same Abandoned AU2001273150A1 (en)

Applications Claiming Priority (52)

Application Number Priority Date Filing Date Title
US21955600P 2000-07-20 2000-07-20
US60/219,556 2000-07-20
US22066600P 2000-07-25 2000-07-25
US22060500P 2000-07-25 2000-07-25
US22062400P 2000-07-25 2000-07-25
US22066400P 2000-07-25 2000-07-25
US22058500P 2000-07-25 2000-07-25
US22060700P 2000-07-25 2000-07-25
US22063800P 2000-07-25 2000-07-25
US60/220,666 2000-07-25
US60/220,607 2000-07-25
US60/220,605 2000-07-25
US60/220,585 2000-07-25
US60/220,638 2000-07-25
US60/220,664 2000-07-25
US60/220,624 2000-07-25
US22089300P 2000-07-26 2000-07-26
US60/220,893 2000-07-26
PCT/US2000/020710 WO2001009327A2 (en) 1999-07-28 2000-07-28 Method of preventing the injury or death of retinal cells and treating ocular diseases
AU63910/00 2000-07-28
US22242500P 2000-08-01 2000-08-01
US60/222,425 2000-08-01
US22713300P 2000-08-22 2000-08-22
US60/227,133 2000-08-22
AU70793/00 2000-08-23
PCT/US2000/023522 WO2001016319A2 (en) 1999-08-31 2000-08-23 Compositions and methods for the treatment of immune related diseases
PCT/US2000/023328 WO2001016318A2 (en) 1999-09-01 2000-08-24 Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU75730/00 2000-08-24
US60/000,000 2000-09-15
AU34346/01 2000-11-10
PCT/US2000/030873 WO2001040465A2 (en) 1999-11-30 2000-11-10 Compositions and methods for the treatment of immune related diseases
US25364600P 2000-11-28 2000-11-28
US60/253,646 2000-11-28
AU20554/01 2000-12-01
PCT/US2000/032678 WO2001040466A2 (en) 1999-12-01 2000-12-01 Secreted and transmembrane polypeptides and nucleic acids encoding the same
PCT/US2000/034956 WO2001046420A2 (en) 1999-12-23 2000-12-20 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof
US09/747,259 2000-12-20
US09/747,259 US6569645B2 (en) 1999-05-14 2000-12-20 IL-17 homologous polypeptides and therapeutic uses thereof
AU25909/01 2000-12-20
AU2001268028 2001-02-28
PCT/US2001/006520 WO2001068848A2 (en) 2000-03-01 2001-02-28 Secreted and transmembrane polypeptides and nucleic acids encoding the same
PCT/US2001/006666 WO2001066740A2 (en) 2000-03-03 2001-03-01 Compositions and methods for the treatment of immune related diseases
AU2001255168 2001-03-01
US09/816,744 2001-03-22
US09/816,744 US6579520B2 (en) 1998-05-15 2001-03-22 IL-17 related mammalian cytokine polypeptides (IL-17E)
US09/854,280 2001-05-10
US09/854,280 US7115398B2 (en) 1998-05-15 2001-05-10 IL-17 homologous polypeptides and therapeutic uses thereof
US09/854,208 US7217412B2 (en) 1998-05-15 2001-05-10 IL-17C related mammalian cytokine polypeptides
US09/854,208 2001-05-10
AU2001265019 2001-05-25
PCT/US2001/017092 WO2001092331A2 (en) 2000-05-30 2001-05-25 Compositions and methods for the treatment of immune related diseases
PCT/US2001/021066 WO2002008288A2 (en) 2000-07-20 2001-06-29 Secreted and transmembrane polypeptides and nucleic acids encoding the same

Publications (1)

Publication Number Publication Date
AU2001273150A1 true AU2001273150A1 (en) 2002-02-05

Family

ID=56290161

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001273150A Abandoned AU2001273150A1 (en) 2000-07-20 2001-06-29 Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU7315001A Pending AU7315001A (en) 2000-07-20 2001-07-02 Secreted and transmembrane polypeptides and nucleic acids encoding the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU7315001A Pending AU7315001A (en) 2000-07-20 2001-07-02 Secreted and transmembrane polypeptides and nucleic acids encoding the same

Country Status (5)

Country Link
EP (1) EP1354040A2 (en)
JP (1) JP2004514420A (en)
AU (2) AU2001273150A1 (en)
CA (1) CA2416456A1 (en)
WO (1) WO2002008288A2 (en)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2301173C (en) 1997-09-12 2015-04-14 Biogen, Inc. Cysteine rich receptors-train
US7771719B1 (en) 2000-01-11 2010-08-10 Genentech, Inc. Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
US20020106728A1 (en) * 2000-06-20 2002-08-08 Genentech, Inc. NS4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
US20030232056A1 (en) 1999-09-10 2003-12-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
DK1897945T3 (en) * 1999-12-23 2012-05-07 Genentech Inc IL-17 homologous polypeptides and therapeutic uses thereof.
EP1666594A3 (en) * 2000-06-02 2006-06-21 Genentech, Inc. Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer
US20030096969A1 (en) 2000-06-02 2003-05-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU6531101A (en) * 2000-06-02 2001-12-17 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030096339A1 (en) 2000-06-26 2003-05-22 Sprecher Cindy A. Cytokine receptor zcytor17
US20030017572A1 (en) * 2000-09-25 2003-01-23 Rajasekhar Bandaru 56294 and 56629, novel human metalloproteases and uses thereof
WO2002026801A2 (en) * 2000-09-28 2002-04-04 Eli Lilly And Company Secreted proteins and their uses
JP2004532609A (en) 2000-11-03 2004-10-28 ザ リージェント オブ ザ ユニバーシティ オブ カリフォルニア Prokineticin polypeptides, related compositions and methods
EP1385993B8 (en) 2000-12-08 2011-09-21 Celldex Therapeutics, Inc. Method of detecting and treating tuberous sclerosis complex associated disorders
DE10106835A1 (en) * 2001-02-14 2002-09-05 Basf Lynx Bioscience Ag Signal transduction proteins 15B3, 15B3-1 and 15B3-2 and underlying DNA sequences
GB2378183A (en) * 2001-04-25 2003-02-05 Smithkline Beecham Corp Assays of the interaction between AXOR8 or AXOR52 and BV-8 ligand
US7157558B2 (en) 2001-06-01 2007-01-02 Genentech, Inc. Polypeptide encoded by a polynucleotide overexpresses in tumors
AU2002327176A1 (en) * 2001-06-06 2002-12-16 Human Genome Sciences, Inc. 20 human secreted proteins
DK1961811T3 (en) 2002-01-18 2010-11-08 Zymogenetics Inc Cytokine ligand for the treatment of asthma and respiratory hyperresponsiveness
JP2005536190A (en) * 2002-04-16 2005-12-02 ジェネンテック・インコーポレーテッド Compositions and methods for tumor diagnosis and treatment
US7141381B2 (en) 2002-04-25 2006-11-28 Bristol-Myers Squibb Company Human leucine-rich repeat-containing proteins specifically expressed in the nervous system
DE60325541D1 (en) 2002-10-31 2009-02-12 Hoffmann La Roche Process / preparation for the detection of pancreatic cancer
DE10254601A1 (en) * 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Gene products differentially expressed in tumors and their use
CA2510314A1 (en) * 2002-12-20 2004-07-15 Avalon Pharmaceuticals, Inc. Breast specific protein expressed in cancer and methods of use thereof
JP4912144B2 (en) 2003-03-12 2012-04-11 ジェネンテック， インコーポレイテッド Use of BV8 and / or EG-VEGF to promote hematopoiesis
US7479479B2 (en) 2003-04-30 2009-01-20 Centocor, Inc. CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses
MXPA05011725A (en) * 2003-04-30 2006-05-17 Johnson & Johnson Cngh0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses.
CA2469094A1 (en) * 2003-07-28 2005-01-28 F. Hoffmann-La Roche Ag Methods for diagnosis and therapy of cancer and composition useful therein
EP1503212B1 (en) * 2003-07-28 2007-05-23 F. Hoffmann-La Roche Ag Methods for diagnosis and therapy of metastasis and composition useful therein
US20100031378A1 (en) 2008-08-04 2010-02-04 Edwards Joel A Novel gene disruptions, compositions and methods relating thereto
EP1739171A4 (en) * 2004-03-02 2008-11-05 Eisai R&D Man Co Ltd Novel gene participating in epidermal differentiation and use thereof
PT1781682E (en) 2004-06-24 2013-05-14 Mayo Foundation B7-h5, a costimulatory polypeptide
KR20070036089A (en) 2004-07-02 2007-04-02 제넨테크, 인크. Methods and therapeutic compositions for non-Hodgkin's lymphoma
EP1789070B1 (en) 2004-08-03 2012-10-24 Biogen Idec MA Inc. Taj in neuronal function
US8101183B2 (en) 2005-05-06 2012-01-24 Zymogentics, Inc. Variable region sequences of IL-31 monoclonal antibodies
KR101443050B1 (en) 2005-05-06 2014-09-22 지모제넥틱스, 인코포레이티드 Il-31 monoclonal antibodies and methods of use
US20130216542A1 (en) 2005-05-06 2013-08-22 Zymogenetics, Inc. Variable region sequences of il-31 monoclonal antibodies and methods of use
JP2007063225A (en) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd Imidazopyridine compound
EP2749571A3 (en) 2006-01-10 2014-08-13 ZymoGenetics, Inc. Methods of treating pain and inflammation in neuronal tissue using IL-31RA and OSMRb antagonists
EP2001875A2 (en) 2006-03-08 2008-12-17 Takeda San Diego, Inc. Glucokinase activators
EP2049518B1 (en) 2006-05-31 2011-08-31 Takeda San Diego, Inc. Indazole and isoindole derivatives as glucokinase activating agents.
US8163779B2 (en) 2006-12-20 2012-04-24 Takeda San Diego, Inc. Glucokinase activators
US8173645B2 (en) 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators
ME03057B (en) 2007-12-07 2019-01-20 Zymogenetics Inc Humanized antibody molecules specific for il-31
RU2474588C2 (en) 2008-05-05 2013-02-10 Новиммун Са Cross-reactive antibodies anti-il-17a/il-17f and methods for use thereof
SMT202300421T1 (en) 2009-02-20 2024-01-10 Astellas Pharma Inc Methods and compositions for diagnosis and treatment of cancer
CN102458437B (en) 2009-05-05 2015-06-10 诺维莫尼公司 Anti-il-17f antibodies and methods of use thereof
DK3305813T3 (en) 2009-11-11 2020-04-20 Astellas Pharma Inc ANTIBODIES SPECIFIC TO CLAUDIN 6 (CLDN6)
EP2404936A1 (en) 2010-07-06 2012-01-11 Ganymed Pharmaceuticals AG Cancer therapy using CLDN6 target-directed antibodies in vivo
ES2989943T3 (en) 2011-05-13 2024-11-28 Astellas Pharma Inc Antibodies for the treatment of cancer expressing Claudin 6
US9848543B2 (en) 2013-07-09 2017-12-26 E I Du Pont De Nemours And Company System and method for irrigation
WO2015014376A1 (en) 2013-07-31 2015-02-05 Biontech Ag Diagnosis and therapy of cancer involving cancer stem cells
GB201810301D0 (en) * 2018-06-22 2018-08-08 Evox Therapeutics Ltd Combinatorial gene therapy
CN111848792B (en) * 2020-07-16 2023-02-24 浙江省食品药品检验研究院 Preparation method and detection method of antibody of bovine serum albumin and other impurities in vaccine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
US6060249A (en) * 1997-02-27 2000-05-09 Genentech, Inc. Method of selection for genes encoding secreted and transmembrane proteins
AU3753499A (en) * 1998-04-20 1999-11-08 Paul B. Fisher Colon cancer-associated antigens and their diagnostic and therapeutic uses
EP1263948A2 (en) * 1999-03-08 2002-12-11 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU3396600A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. 49 human secreted proteins
EP1208195A2 (en) * 1999-06-15 2002-05-29 Genentech Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2001055301A2 (en) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
AU6531101A (en) * 2000-06-02 2001-12-17 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same

Also Published As

Publication number Publication date
EP1354040A2 (en) 2003-10-22
JP2004514420A (en) 2004-05-20
WO2002008288A2 (en) 2002-01-31
WO2002008288A3 (en) 2003-08-14
AU7315001A (en) 2002-01-30
CA2416456A1 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
AU2001268028A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2001273150A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2001265311A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2002216610A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU7573000A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2055401A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2883700A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2883900A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
IL139686A0 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
IL188577A0 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO1999046281A8 (en) Novel polypeptides and nucleic acids encoding the same
IL141535A0 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2001249394A1 (en) Secreted proteins and polynucleotides encoding them
AU2001239889A1 (en) Polypeptides and nucleic acids encoding same
AU2001234896A1 (en) Novel polypeptides and nucleic acids encoding same
AU1453601A (en) Novel polypeptides and nucleic acids encoding same
KR100514265B1 (en) Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same
KR100532172B1 (en) Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same
AU5152700A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
KR100528420B1 (en) Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same
KR100473124B1 (en) Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same
AU2001234627A1 (en) Novel polypeptides and nucleic acids encoding same
WO2002032961A8 (en) Novel polypeptides and nucleic acids encoding same
AU2001227925A1 (en) Odorant receptor polypeptides and nucleic acids encoding same
AU2001289282A1 (en) Secreted proteins and polynucleotides encoding them

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase